305 related articles for article (PubMed ID: 32005245)
1. Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy.
Thumser-Henner P; Nytko KJ; Rohrer Bley C
BMC Vet Res; 2020 Jan; 16(1):30. PubMed ID: 32005245
[TBL] [Abstract][Full Text] [Related]
2. Somatic SNPs of the BRCA2 gene at the fragments encoding RAD51 binding sites of canine mammary tumors.
Ozmen O; Kul S; Risvanli A; Ozalp G; Sabuncu A; Kul O
Vet Comp Oncol; 2017 Dec; 15(4):1479-1486. PubMed ID: 28133886
[TBL] [Abstract][Full Text] [Related]
3. Common germline haplotypes and genotypes identified in BRCA2 exon 11 of dogs with mammary tumours and histopathological analyses.
Maués T; El-Jaick KB; Costa FB; Araujo GEF; Soares MVG; Moreira AS; Ferreira MLG; Ferreira AMR
Vet Comp Oncol; 2018 Sep; 16(3):379-384. PubMed ID: 29512278
[TBL] [Abstract][Full Text] [Related]
4. Cloning and sequencing full length of canine Brca2 and Rad51 cDNA.
Ochiai K; Morimatsu M; Tomizawa N; Syuto B
J Vet Med Sci; 2001 Oct; 63(10):1103-8. PubMed ID: 11714026
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue.
Hsu WL; Huang YH; Chang TJ; Wong ML; Chang SC
Vet J; 2010 Jun; 184(3):351-6. PubMed ID: 19944633
[TBL] [Abstract][Full Text] [Related]
6. Reduced canine BRCA2 expression levels in mammary gland tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Wada S; Orino K; Watanabe K
BMC Vet Res; 2015 Jul; 11():159. PubMed ID: 26202431
[TBL] [Abstract][Full Text] [Related]
7. Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3.
Yoshikawa Y; Ochiai K; Morimatsu M; Suzuki Y; Wada S; Taoda T; Iwai S; Chikazawa S; Orino K; Watanabe K
PLoS One; 2012; 7(10):e45833. PubMed ID: 23071527
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.
Enginler SO; Akış I; Toydemir TS; Oztabak K; Haktanir D; Gündüz MC; Kırşan I; Fırat I
Vet Res Commun; 2014 Mar; 38(1):21-7. PubMed ID: 24122022
[TBL] [Abstract][Full Text] [Related]
9. Interactions between canine RAD51 and full length or truncated BRCA2 BRC repeats.
Ochiai K; Yoshikawa Y; Oonuma T; Tomioka Y; Hashizume K; Morimatsu M
Vet J; 2011 Nov; 190(2):293-295. PubMed ID: 21123097
[TBL] [Abstract][Full Text] [Related]
10. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
[TBL] [Abstract][Full Text] [Related]
12. Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes.
Canadas A; Santos M; Nogueira A; Assis J; Gomes M; Lemos C; Medeiros R; Dias-Pereira P
J Vet Diagn Invest; 2018 Sep; 30(5):733-738. PubMed ID: 30027822
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.
Evers B; Drost R; Schut E; de Bruin M; van der Burg E; Derksen PW; Holstege H; Liu X; van Drunen E; Beverloo HB; Smith GC; Martin NM; Lau A; O'Connor MJ; Jonkers J
Clin Cancer Res; 2008 Jun; 14(12):3916-25. PubMed ID: 18559613
[TBL] [Abstract][Full Text] [Related]
14. Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Yamane Y; Tomizawa N; Sasaki N; Hashizume K
J Vet Med Sci; 2005 Oct; 67(10):1013-7. PubMed ID: 16276057
[TBL] [Abstract][Full Text] [Related]
15. The canine RAD51 mutation leads to the attenuation of interaction with PALB2.
Uemura M; Ochiai K; Morimatsu M; Michishita M; Onozawa E; Azakami D; Uno Y; Yoshikawa Y; Sasaki T; Watanabe M; Omi T
Vet Comp Oncol; 2020 Jun; 18(2):247-255. PubMed ID: 31518051
[TBL] [Abstract][Full Text] [Related]
16. Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2.
Yoshikawa Y; Morimatsu M; Ochiai K; Ishiguro-Oonuma T; Morioka R; Okuda K; Orino K
J Vet Med Sci; 2021 May; 83(5):759-766. PubMed ID: 33731496
[TBL] [Abstract][Full Text] [Related]
17. [From poly(ADP-ribose) discovery to PARP inhibitors in cancer therapy].
Schreiber V; Illuzzi G; Héberlé E; Dantzer F
Bull Cancer; 2015 Oct; 102(10):863-73. PubMed ID: 26384693
[TBL] [Abstract][Full Text] [Related]
18. Molecular biological aspects on canine and human mammary tumors.
Rivera P; von Euler H
Vet Pathol; 2011 Jan; 48(1):132-46. PubMed ID: 21147766
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.
de Oliveira JR; Colombo J; Gonçalves FM; de Carvalho LAL; Costa DS; Henrique T; Novais AA; Moschetta-Pinheiro MG; Chuffa LGA; Coutinho LL; Santana ÁE; Zuccari DAPC
Vet Comp Oncol; 2022 Mar; 20(1):164-171. PubMed ID: 34328705
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a PCR analysis method for canine BRCA2.
Yoshikawa Y; Morimatsu M; Ochiai K; Okuda K; Taoda T; Chikazawa S; Shimamura A; Omi T; Bonkobara M; Orino K; Watanabe K
BMC Res Notes; 2012 Apr; 5():173. PubMed ID: 22471976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
